Q4 Outlook - The Future of Humans

Tuesday, 29 September 2020

The markets have staged a spectacular V-shape recovery with the Tech sector leading the charge. Today, the Big 5 tech stocks account for 25% of the S&P Index.

As we head into Q42020, what lies ahead for investors? Does Tech have further to go or does this feel like Dotcom Bubble 2.0? Should we rotate into laggards? Helping us make sense of Disruptive stocks and the new order will be our invited keynote speaker Professor Aswath Damodaran, Wall Street's Dean of Valuation and Finance Professor at NYU School of Stern.

Beyond Q4, we will have a look at the Future of Humans and how Technology will enable and accelerate innovation in the areas of Education, Healthcare and Consumer Behavior. Our CIO office will also share updates on key top of mind topics such as vaccine development, US elections and Gold.

Interested in joining our webinar?

Please register your interest by clicking the contact us button below.

Agenda

Time

Topic

09.30 – 09.35

Welcome address

August Hatecke, Co-Head Wealth Management Asia Pacific, UBS Global Wealth Management

09.35 – 09.55

CIO Outlook 

Our speakers will address our house views on 5 top of mind questions that investors have and our recommended positioning heading into 4Q..

Min Lan Tan, Head Chief Investment Office APAC, UBS Global Wealth Management

John Savercool, Managing Director and Senior Lobbyist, UBS Americas

09.55 – 10.20

Keynote – How to value Disruptive stocks?

Widely known as Wall Street's "Dean of Valuation", our keynote speaker Aswath Damodaran will be at hand to help us make sense of how disruption is changing markets, business models and how stocks are valued.

Aswath Damodaran, Professor of Finance, New York University School of Stern

10.20 – 10.55

Future of Humans

The Future of Human uncovers how tech is enabling innovation and accelerating forward trends in Healthcare, Education and Consumer Behaviours.

Kelvin Tay, Regional Chief Investment Officer, UBS Global Wealth Management

Kuldeep Singh Rajput, Founder and CEO of Biofourmis

Raymond Moh, Co-Founder and CEO of BioMind®

August HATECKE

Group Managing Director & Co-Head Asia Pacific, UBS AG

August Hatecke was appointed Co-Head UBS AG Asia Pacific with effect from 1 January 2019 and Country Head Singapore on 19 February 2019. He has been Head of UBS AG South East Asia since April 2016 and additionally Head of UBS Wealth since June 2017. August previously served as UBS Head of Ultra High Net Worth and Global Family Office Switzerland based in Zurich where he was responsible for managing the needs of wealthy clients in Switzerland.

August started his career with the Investment Banking arm of SBC O'Connor Warburg Dillon Read in 1992 before moving to Private Banking where he was working on Active Advisory, Portfolio Management, Treasury and Execution. He was with Credit Suisse AG for the period 2001-2010 where he headed teams in Private Banking Switzerland, Investment Services and Products as well as Trading and Sales.

Since returning to UBS in 2010, he has been responsible for the Ultra High Net Worth and Global Family Office business for UBS Switzerland AG.

August holds a Master Degree in Economics from the University of Zurich.


Min Lan TAN

Group Managing Director,
UBS AG

Min Lan Tan is the Head of the Asia Pacific Investment Office at UBS AG, since July 2013. She serves as a member of the Global Investment Committee, Emerging Market Investment Committee and Asia Investment Committee, which formulate the regional and global UBS House View.

Prior to joining UBS AG, Min Lan spent eleven years with the UBS Investment Bank where she held a number of senior appointments. From 2002-2012, Min Lan was the Head of Research and Strategist at UBS Securities Singapore. Over this period, Min Lan was ranked a top analyst in Asia across major institutional investor surveys, including being named the Number 1 analyst in Singapore by Asiamoney for ten straight years. From 2006, she was concurrently appointed the Head of Equities for Singapore, with oversight of research, sales, trading and execution, prime brokerage and exchange traded derivatives. In 2012, Min Lan was made the Global Head of FICC Macro Strategy Research, where she was in charge of teams covering global asset allocation, global emerging markets, fixed income, FX and credit research.

Before joining UBS, Min Lan worked as a senior economist with the Econometric Modelling unit at the Monetary Authority of Singapore, as well as an economist and strategist at Merrill Lynch covering the Asian equities markets.

Min Lan holds a Bachelor in Accountancy (Hons) from the National University of Singapore and is a CFA charter holder. She sits on the Board of Trustees of the Singapore University of Technology and Design (SUTD).


John
SAVERCOOL

Managing Director and Senior Lobbyist, UBS Americas

John Savercool serves as Managing Director and Head of the UBS U.S. Office of Public Policy. This office covers all of the primary business units within UBS, including the Investment Bank, Wealth Management and Global AM. In this capacity, John directs the firm’s lobbying, political and policy advocacy efforts at the federal level. He manages a staff of five in Washington in support of this mission.

John is a veteran of Washington of 34 years. He began his career with U.S. Congressman Mike Oxley of Ohio and former chairman of the House Financial Services Committee. John then embarked on a

17-year career with Texas Senator Phil Gramm, the former chairman of the Senate Banking Committee. John also served as chief of staff for Texas Senator Kay Bailey Hutchison in 1993. In his long Senate career, John focused on a broad range of legislative and policy issues.

John left the Senate in 1999 for a career in the private sector. He was tapped to be the vice president for federal affairs for the American Insurance Association (AIA) in 1999 and served in that capacity until 2003. While at the AIA, John spearheaded the insurance industry’s efforts in passing the Terrorism Risk Insurance Act of 2002. He also led the industry’s efforts to open new markets for U.S. property and casualty insurance products abroad, specifically in China and India.

In 2003, he was selected by UBS to become the firm’s first full-time, senior lobbyist to direct the firm’s advocacy activities in Washington. John’s lobbying targets to date have included all major banking and securities issues, regulatory reform in financial services and tax legislation, among others. John also directs the firm’s political action committee and manages the firm’s political relationships in Washington. Within UBS, John serves on a number of high-level operations, cross-business coordination and risk management committees that drive business and operating activities in the U.S., Canada and Latin/South America.

John was born in Endicott, New York and is a graduate of Frostburg State University (Maryland). He has spent most of his life in the Washington, D.C. suburbs where he currently lives with his wife Mary K. John and Mary K. have two grown daughters and a grown son.


Raymond Moh

Co-Founder and CEO of BioMind®

Raymond is the co-founder and CEO of BioMind®, an award- winning artificial intelligence company in medical imaging and clinical decision support system. Together with his team of over 200 in-house machine learning engineers and medically-trained talents, the company has developed and commercialised AI applications to assist in the diagnosis and treatment of a wide spectrum of neurological disorders including brain tumors, vascular diseases, stroke and many others.

BioMind® has been crowned the winner of Techblazer Award 2019, Singapore's highest accolade for tech innovation, winner of the 19th Asia Pacific ICT Alliance Award (ICT and Security Category), listed as Top 8 innovations in Arab Health, conferred the top AI award for COVID-19 detection at World AI Conference  2020 and leads the radiotherapy focus group AI4H established by the World Health Organisation.

Prior to founding BioMind, Raymond graduated from the pioneer cohort of the prestigious National University of Singapore (NUS) Engineering and Business Double Degree Program. Since 2013, he has served as a scholar and advised over 50 organisations to achieve high growth rate and productivity driven by technology adoptions. In 2019, he has launched the inaugural Healthcare Machine Learning PhD Program in NUS and also led the technology piece in the Future City Program of Singapore to groom the next generation of AI talents in healthcare.

Aswath DAMODA-RAN

Professor of Finance, New York University School of Stern

Aswath Damodaran is the Kerschner Family Chair Professor of Finance at the Stern School of Business at New York University. He teaches the corporate finance and valuation courses in the MBA program. He received his MBA and Ph.D from the University of California at Los Angeles. His research interests lie in valuation, portfolio management and applied corporate finance. He has published in the Journal of Financial and Quantitative Analysis, the Journal of Finance, the Journal of Financial Economics and the Review of Financial Studies.

He has written four books on valuation (Damodaran on Valuation, Investment Valuation, The Dark Side of Valuation, The Little Book of Valuation), and two on corporate finance (Corporate Finance: Theory and Practice, Applied Corporate Finance: A User’s Manual). He has co-edited a book on investment management with Peter Bernstein (Investment Management), has a book on investment philosophies (Investment Philosophies) and one on “can’t miss” investment strategies, titled Investment Fables. He also has a book on the relationship between risk and value, Strategic Risk Taking, which takes a big picture view of how risk management affects value. His newest book is titled Narrative and Numbers: The Value of Stories in Business and is about how to connect storytelling to valuation.

Aswath was a visiting lecturer at the University of California, Berkeley, from 1984 to 1986, where he received the Earl Cheit Outstanding Teaching Award in 1985. He has been at NYU since 1986, received the Stern School of Business Excellence in Teaching Award (awarded by the graduating class) in 1988, 1991, 1992, 1999, 2001, 2007, 2008, 2009 and 2013, and was the youngest winner of the University-wide Distinguished Teaching Award (in 1990). He was profiled in Business Week as one of the top twelve business school professors in the United States in 1994 and was elected as the most popular business school professor in the US by MBA students across the country in a 2011 survey by Business Week. In 2012, he was chosen as one of the top ten business school professors in the world by Poets and Quants, and his blog, Musings on Markets, was selected by the Times of London as one of the top ten stock market blogs in the world. Of course, as with any finance-oriented post, it should be emphasized that past performance is not an indicator of future results.

In addition to his blog, Aswath has an active presence online, on Twitter (@AswathDamodaran) and with his website (http://www.damodaran.com). His corporate finance and valuation classes are carried online and on iTunes U (with more than 100,000 students on iTunes U) and his online classes were chosen as one of the top ten MOOCs in the world in 2012.


Kelvin TAY

Managing Director,
UBS AG

Kelvin Tay is the Regional Chief Investment Officer at UBS AG. Kelvin is a member of the UBS Global Emerging Markets Investment Committee, as well as the Asia-Pacific Investment Committee where he provides strategic research and inputs to the investment and asset allocation process across asset classes.

Based in Singapore, Kelvin joined UBS AG Asia in April 2006 and was deputy head of P&S Consulting (Southeast Asia), where he helped clients structure investment portfolios based on asset allocation. Prior to joining UBS, Kelvin worked at Deutsche Bank Private Wealth Management (Asia) as the Asian & European Equity Strategist responsible for Asian & European equity selection. He was also the portfolio manager of the Asian equities portfolio and was also responsible for conducting funds research.

From 2002 to 2004, Kelvin was a Regional Telecoms Analyst with JPMorgan Chase where he was consistently one of the top 3 rated regional Asian telecoms analysts in international surveys such as AsiaMoney and Institutional Investor.

From 2000 to 2002, Kelvin was a Regional Telecoms Analyst with ABN AMRO (Asia) Ltd in Hong Kong, where he was ranked No.3 in AsiaMoney's Asia-wide regional telecoms analyst survey in 2001 and his team was ranked No. 1 in the 2000 Greenwich survey. Prior to that, Kelvin worked at Overseas Union Bank in Singapore as a credit analyst in loan syndications and capital markets.


Kuldeep Singh RAJPUT

Founder and CEO of Biofourmis

Kuldeep Singh Rajput is the CEO and Founder of Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care. Biofourmis is pioneering an entirely new category of digital health, with its clinically validated software-based therapeutics and wearables platform that provide better outcomes for patients, smarter engagement and tracking tools for clinicians, technology to complement and demonstrate the value of pharmacotherapy, and cost-effective solutions for payers. Recognized as a “Forbes 30 Under 30,” Rajput has demonstrated strong leadership experience with building teams, developing talent, and successfully growing and managing strategic partnerships with global pharmaceutical manufacturers, health systems and payers. Under his leadership, Biofourmis has raised over $145 Million in venture capital from leading Venture Capital firms including SoftBank Vision Fund, Sequoia Capital, MassMutual Ventures, Openspace Ventures, and Mayo Clinic Ventures.


Recommended Reading

Humanity is facing two important trends. Over the next 30 years, our numbers will grow and our average age will increase. These demographic trends are taking place alongside huge structural shifts. The Fourth Industrial Revolution— powered by automation and connectivity—and the environmental credit crunch will dramatically alter the way the global economy works. All these issues are entwined, but what do they mean for investors?
 
In this report, we consider some of the biggest areas of change for humankind—driven primarily by demographic shifts and enabled mainly by technology—and the associated investment implications. We expect changes to be largest in three key areas: education, healthcare, and happiness and consumer preferences. Discover what investing for the future means in our Future of humans report.